| 摘要 |
1-(Alkoxy-iminoalkyl)imidazole derivatives of formula (I), wherein R is hydrogen or C1-C4 alkyl; A is C1-C4 alkylene optionally substituted by phenyl optionally substituted by halogen or trifluoromethyl; R is (a) hydrogen or a C1-C10 hydrocarbon radical; (b) an aryl or aryl-C1-C4 alkyl group wherein the said aryl is optionally substituted either by halogen, trihalo-methyl, C1-C4 alkyl, C2-C3 alkenyl, C2-C6 alkynyl, C1-C4 alkoxy, C1-C4 alkylthio or C1-C4 alkylsulfonyl or by C5-C8 alkyl, C4-C8 alkenyl, C5-C8 alkoxy, C5-C8 alkylthio or phenyl optionally substituted by halogen, trihalomethyl or C1-C4 alkyl; or (c) a C5-C8 cycloalkyl or C5-C8 cycloalkyl-C1-C4 alkyl group, wherein the said cycloalkyl is optionally substituted by C1-C4 alkyl; T is a C1-C6 hydrocarbon chain or phenylene; X is a bond, -O-CH2-, -C(R' R'')-, Si(R' R'')-, vinylene or isopropenylene, each R' and R'' being hydrogen, fluorine or C1-C4 alkyl; and R2 is -OR3 or -N(R3R4), each R3 and R4 being hydrogen, C1-C6 alkyl, phenyl or benzyl; and the pharmaceutically acceptable salts thereof; are useful in the treatment of a disease state related to enhancement of thromboxane A2 (TxA2) synthesis.
|
